Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapy.

Xia Jin; Murugappan Ramanathan; Shady Barsoum; Geoffrey R Deschenes; Lei Ba; James Binley; Daryl Schiller; Daniel E Bauer; Donald C Chen; Arlene Hurley

doi:10.1128/jvi.76.5.2206-2216.2002

Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapy.

Identifier:nobleid.org/w1/20260515/9FB4DF2D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/9FB4DF2D.svg?ark=w1%2F20260515%2F9FB4DF2D)](https://nobleid.org/work/w1/20260515/9FB4DF2D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Xia Jin

Murugappan Ramanathan

Claim authorship of this work

Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapy.

Identifier:nobleid.org/w1/20260515/9FB4DF2D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/9FB4DF2D.svg?ark=w1%2F20260515%2F9FB4DF2D)](https://nobleid.org/work/w1/20260515/9FB4DF2D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Xia Jin

Murugappan Ramanathan

Claim authorship of this work